Richard Eberly - Mar 11, 2022 Form 4 Insider Report for CHEMBIO DIAGNOSTICS, INC. (CEMI)

Signature
/s/ Mark L. Johnson, Attorney-in-Fact for Richard Eberly
Stock symbol
CEMI
Transactions as of
Mar 11, 2022
Transactions value $
$0
Form type
4
Date filed
3/15/2022, 09:30 PM
Next filing
May 1, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CEMI Restricted Stock Units Award $0 +432K $0.00 432K Mar 11, 2021 Common Stock 432K Direct F1, F2
transaction CEMI Incentive Stock Options Award $0 +143K $0.00 143K Mar 11, 2021 Common Stock 143K $1.25 Direct F3
transaction CEMI Nonqualified Stock Options Award $0 +690K $0.00 690K Mar 11, 2021 Common Stock 690K $1.25 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 On March 16, 2020, the reporting person was granted 432,000 restricted stock units scheduled to vest in equal installments on March 11 of each of 2023, 2024 and 2025, subject to continued service through each vesting date.
F3 The incentive stock options are scheduled to vest and become exercisable over four years, with two shares vesting on March 11, 2023, two shares vesting on March 11, 2024, two shares vesting on March 11, 2025 and the remaining 143,061 shares vesting on March 11, 2026, subject to continued service through each vesting date.
F4 The nonqualified stock options are scheduled to vest and become exercisable over four years, with one-fourth vesting on March 15, 2023, one-fourth vesting on March 11, 2024, one-fourth vesting on March 15, 2025 and the remaining one-fourth vesting on March 15, 2026, subject to continued service through each vesting date.

Remarks:

President and Chief Executive Officer